Increased sequestration of matrix metalloproteinases in ageing human bruch's membrane: Implications for ECM turnover

Investigative Ophthalmology and Visual Science

Volumn 51, Issue 5, 2010, Pages 2664-2670

  Kumar, Anupma ^a   El Osta, Austen ^a   Hussain, Ali A ^a   Marshall, John ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GELATIN; GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE; POLYMER;

ADULT; AGED; AGING; ARTICLE; BRUCH MEMBRANE; CELL ACTIVATION; CELL METABOLISM; CONTROLLED STUDY; DENSITOMETRY; ENZYME RELEASE; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; HUMAN TISSUE; MOLECULAR WEIGHT; PRIORITY JOURNAL; PROTEIN LOCALIZATION; ZYMOGRAPHY; ENZYMOLOGY; FEMALE; MALE; METABOLISM; MIDDLE AGED; PHYSIOLOGY;

ADULT; AGED; AGED, 80 AND OVER; AGING; BRUCH MEMBRANE; DENSITOMETRY; EXTRACELLULAR MATRIX; FEMALE; HUMANS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; YOUNG ADULT;

EID: 77952530576     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.09-4195     Document Type: Article

References (40)

1. Marshall J, Hussain AA, Starita C, Moore DJ, Patmore A. Ageing and Bruch's membrane. In: Marmor MF, Wolfensberger TJ, eds. Retinal Pigment Epithelium: Function and Disease. New York: Oxford University Press; 1998:669-692.
2. Kamei M, Hollyfield JG. TIMP-3 in Bruch's membrane: changes during aging and in age-related macular degeneration. Invest Ophthalmol Vis Sci. 1999;40:2367-2375.
3. Bergers G, Coussens LM. Extrinsic regulators of epithelial tumor progression: metalloproteinases. Curr Opin Genet Dev. 2000;10:120-127.
4. Matrisian LM. The matrix degrading metalloproteinases. BioEssays. 1992;14:455-463.
5. Woessner JF. Matrix metalloproteinases and their inhibitors in connective tissue remodelling. FASEB J. 1991;5:2145-2154.
6. Murphy G, Crabbe T. Gelatinases: A and B. Methods Enzymol. 1995;248:470-484.
7. Birkedal-Hansen H, Moore WGL, Bodden MK, et al. Matrix metalloproteinases: a review. Crit Rev Oral Biol Med. 1993;4:197-250.
8. Guo L, Hussain AA, Limb GA, Marshall J. Age-dependent variation in the metalloproteinase activity of isolated Bruch's membrane and choroid. Invest Ophthalmol Vis Sci. 1999;40:2676-2682.
9. Hunt RC, Fox A, Pakalnis VAL, et al. Cytokines cause cultured retinal pigment epithelial cells to secrete metalloproteinases and to contract collagen gels. Invest Ophthalmol Vis Sci. 1993;34:3179-3186.
10. Alexander JP, Bradley JMB, Gabourel JD, Acott TS. Expression of matrix metalloproteinases and inhibitor by human retinal pigment epithelium. Invest Ophthalmol Vis Sci. 1990;31:2520-2528.
11. Vranka JA, Johnson E, Zhu X, et al. Discrete expression and distribution pattern of TIMP-3 in the human retina and choroid. Curr Eye Res. 1997;16:102-110.
12. Fariss RN, Apte SS, Olsen BR, Iwata K, Milam AH. Tissue inhibitor of metalloproteinases-3 is a component of Bruch's membrane of the eye. Am J Pathol. 1997;150:323-328.
13. Fariss RN, Apte SS, Luthert PJ, Bird AC, Milam AH. Accumulation of tissue inhibitor of metalloproteinases-3 in human eyes with Sorsby's fundus dystrophy or retinitis pigmentosa. Br J Ophthalmol. 1998;82:1329-1334.
14. Weber BH, Vogt G, Pruett RC, Stohr H, Felbor U. Mutations in the tissue inhibitor of metalloproteinase-3 (TIMP-3) in patients with Sorsby's fundus dystrophy. Nat Genet. 1994;8:352-356.
15. Klenotic PA, Munier FL, Marmorstein LY, Apte BA. Tissue inhibitor of metalloproteinases-3 (TIMP-3) is a binding partner of epithelial growth factor-containing fibulin-like extracellular matrix protein1 (EFEMP1). J Biol Chem. 2004;279:30469-30473.
16. Marmorstein LY, Munier FL, Arsenijevic Y, et al. Aberrant accumulation of EFEMP1 underlies drusen formation in Malattia Leventinese and age-related macular degeneration. Proc Natl Acad Sci USA. 2002;99:13067-13072.
17. Ramratten RS, van der Schaft TL, Mooy CM, de Bruijn WC, Mulder PGH, de Jong PTVM. Morphometric analysis of Bruch's membrane, the choriocapillaris and the choroid in ageing. Invest Ophthalmol Vis Sci. 1994;35:2857-2864.
18. Okubo A, Rosa RH, Bunce CV, et al. The relationships of age changes in retinal pigment epithelium and Bruch's membrane. Invest Ophthalmol Vis Sci. 1999;40:443-449.
19. Karwatowski WSS, Jefferies TE, Duance VC, Albon J, Bailey AJ, Easty DL. Preparation of Bruch's membrane and analysis of the age related changes in the structural collagens. Br J Ophthalmol. 1995;79:944-952.
20. Pauleikhoff D, Zuels S, Sheraidah G, Marshall J, Wessing A, Bird AC. Correlation between biochemical composition and fluorescein binding of deposits in Bruch's membrane. Ophthalmology. 1992; 99:1548-1553.
21. Holz FG, Sheraidah GS, Pauleikhoff D, Bird AC. Analysis of lipid deposits extracted from human macular and peripheral Bruch's membrane. Arch Ophthalmol. 1994;112:402-406.
22. Moshal KS, Singh M, Sen U, et al. Homocysteine-mediated activation and mitochondrial translocation of calpain regulates MMP-9 in MVEC. Am J Physiol Circ Physiol. 2006;291:H2825-H2835.
23. Striker GE, Praddaude F, Alcazar O, Cousins SW, Marin-Castano ME. Regulation of angiotensin II receptors and extracellular matrix turnover in human retinal pigment epithelium: role of angiotensin II. Am J Physiol Cell Physiol. 2008;295:C1633-C1646.
24. Hoffmann S, He S, Ehren M, Ryan S, Wiedemann P, Hinton DR. MMP-2 and MMP-9 secretion by RPE is stimulated by angiogenic molecules found in choroidal neovascular membranes. Retina. 2006;26:454-461.
25. Alcazar O, Cousins SW, Marin-Castano ME. MMP-14 and TIMP-2 overexpression protects against hydroquinone-induced oxidant injury in RPE: implications for extracellular matrix turnover. Invest Ophthalmol Vis Sci. 2007;48:5662-5670.
26. Strongin AY, Collier I, Bannikov G, Marmer BL, Grant GA, Goldberg GI. Mechanism of cell surface activation of 72kDa type IV collagenase: isolation of the activated form of the membrane metalloproteinase. J Biol Chem. 1995;270:5331-5338.
27. Smine A, Plantner JJ. Membrane type-1 matrix metalloproteinase in human ocular tissues. Curr Eye Res. 1997;16:925-929.
28. Butler GS, Butler MJ, Atkinson SJ, et al. The TIMP-2 membrane type I metalloproteinase 'receptor' regulates the concentration and efficient activation of progelatinase A: a kinetic study. J Biol Chem. 1998;273:871-880.
29. Starita C, Hussain AA, Patmore A, Marshall J. Localisation of the site of major resistance to fluid transport across human Bruch's membrane. Invest Ophthalmol Vis Sci. 1997;38:762-767.
30. Moore DJ, Hussain AA, Marshall J. Age-related variation in the hydraulic conductivity of Bruch's membrane. Invest Ophthalmol Vis Sci. 1995;36:1290-1297.
31. Starita C, Hussain AA, Pagliarini S, Marshall J. Hydrodynamics of ageing Bruch's membrane: implications for macular disease. Exp Eye Res. 1996;62:565-572.
32. Green WR, Enger C. Age-related nacular degeneration histopathologic studies: the Lorenz E. Zimmerman Lecture. Ophthalmology. 1993;100:1519-1535.
33. Nagai N, Klimava A, Lee W-H, Izumi-Nagai K, Handa JT. CTGF is increased in basal deposits and regulates matrix production through the ERK (p42/p44 mapk) MAPK and the p38 MAPK signalling pathways. Invest Ophthalmol Vis Sci. 2009;50:1903-1910.
34. Murphy G, Knauper V. Relating MMP structure to function: why the 'hemopexin' domain? Matrix Biol. 1997;15:511-518.
35. Ahir A, Guo L, Hussain AA, Marshall J. Expression of metalloproteinases from human retinal pigment epithelium cells and their effects on the hydraulic conductivity of Bruch's membrane. Invest Ophthalmol Vis Sci. 2002;43:458-465.
36. Yamada Y, Ishibashi K, Ishibashi K et al. The expression of advanced glycation endproduct receptors in RPE cells associated with basal deposits in human maculas. Exp Eye Res. 2006;82:840-848.
37. Mott JD, Khalifah RG, Nagase H, Shield CF, Hudson JK, Hudson BG. Nonenzymatic glycation of type IV collagen and matrix metalloproteinase susceptibility. Kidney Int. 1997;52:1302-1312.
38. Hamlin CR, Kohn RR. Evidence for progressive, age-related structural changes in post-mature human collagen. Biochim Biophys Acta. 1971;236:458-467.
39. Vater CA, Harris ED, Siegel RE. Native cross-links in collagen fibrils induce resistance to human synovial collagenase. Biochem J. 1979; 181:639-645.
40. Moore DJ, Clover GM. The effect of age on the macromolecular permeability of human Bruch's membrane. Invest Ophthalmol Vis Sci. 2001;42:2970-2975.